Dimension Capital, a venture capital firm, has successfully raised $500 million for its second fund, Dimension II, aimed at investing in startups at the intersection of technology and life sciences. The fund seeks to support and partner with leading entrepreneurs in these fields, capitalizing on the convergence of AI and medical advances. The announcement was made by Dimension Capital itself, with several industry observers and news outlets reporting on the event, highlighting the firm's commitment to providing fresh capital to the leading builders in these innovative sectors.